Docetaxel Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 20 mg/0.5 mL, 80 mg/2 mL, 160 mg/4 mL
Reference Brands: Taxotere® (US & EU), Docefrez® (EU)
Category: Oncology Cancer Care
Docetaxel is available in Injection and strengths such as 20 mg/0.5 mL, 80 mg/2 mL, 160 mg/4 mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Docetaxel is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Docetaxel can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description: Docetaxel Injection is a widely used cytotoxic chemotherapy drug indicated for breast, lung, prostate, gastric, and head & neck cancers. We offer Docetaxel in EU-GMP and USFDA-compliant injectable formulations, including 20 mg, 80 mg, and 160 mg single-use vials. Available for B2B supply, contract manufacturing, and licensing, our Docetaxel meets global regulatory standards with full CTD dossiers and stability data. Alcohol-free and solvent-based options are available. Ideal for distributors, hospitals, and procurement agencies seeking high-quality oncology products. Partner with us for reliable Docetaxel bulk supply or private label opportunities across Europe, the US, and emerging regulated markets.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Crinecerfont
Strength:
50 mg, 100 mg, 50 mg/mL
Form: Capsule / Oral solution
Reference Brands: Crenessity (USA)
View Details
Quick Response Guaranteed | Verified Suppliers
